Cargando…

Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer

BACKGROUND: Additional surgery is recommended when early colorectal cancer (ECRC) is resected by non-curative endoscopic submucosal dissection (ESD) and there is significant risk of lymph node metastasis (LNM). The aim of this study was to investigate the efficacy and safety of additional surgery af...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tao, Zhang, Yi-Qun, Chen, Wei-Feng, Hou, Ying-Yong, Yao, Li-Qing, Zhong, Yun-Shi, Xu, Mei-Dong, Zhou, Ping-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704364/
https://www.ncbi.nlm.nih.gov/pubmed/29183272
http://dx.doi.org/10.1186/s12876-017-0701-y
_version_ 1783281877501607936
author Chen, Tao
Zhang, Yi-Qun
Chen, Wei-Feng
Hou, Ying-Yong
Yao, Li-Qing
Zhong, Yun-Shi
Xu, Mei-Dong
Zhou, Ping-Hong
author_facet Chen, Tao
Zhang, Yi-Qun
Chen, Wei-Feng
Hou, Ying-Yong
Yao, Li-Qing
Zhong, Yun-Shi
Xu, Mei-Dong
Zhou, Ping-Hong
author_sort Chen, Tao
collection PubMed
description BACKGROUND: Additional surgery is recommended when early colorectal cancer (ECRC) is resected by non-curative endoscopic submucosal dissection (ESD) and there is significant risk of lymph node metastasis (LNM). The aim of this study was to investigate the efficacy and safety of additional surgery after non-curative ESD for ECRC and evaluate long-term outcomes. METHODS: Patients with ECRC who underwent ESD and additional surgery between July 2007 and November 2013 were identified. Histology and patient data were collected during an average period of more than 5 years to determine tumor stage and type, resection status, complications, tumor recurrence, and distant metastasis. RESULTS: Fifty-one patients who underwent additional surgery were eligible for analysis. Overall, regional LNM was detected in 5 patients (9.8%) and presence of lymphovascular infiltration was a significant risk factor. Surgery-related complications occurred in 3 patients (5.9%). During a median follow-up period of 59 months, no metastasis or local recurrence was observed. Three patients died of other diseases and no CRC-related deaths took place. CONCLUSIONS: Additional surgery after non-curative ESD for ECRC is effective and safe and should be encouraged to foster curative treatment and better long-term outcomes.
format Online
Article
Text
id pubmed-5704364
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57043642017-12-05 Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer Chen, Tao Zhang, Yi-Qun Chen, Wei-Feng Hou, Ying-Yong Yao, Li-Qing Zhong, Yun-Shi Xu, Mei-Dong Zhou, Ping-Hong BMC Gastroenterol Research Article BACKGROUND: Additional surgery is recommended when early colorectal cancer (ECRC) is resected by non-curative endoscopic submucosal dissection (ESD) and there is significant risk of lymph node metastasis (LNM). The aim of this study was to investigate the efficacy and safety of additional surgery after non-curative ESD for ECRC and evaluate long-term outcomes. METHODS: Patients with ECRC who underwent ESD and additional surgery between July 2007 and November 2013 were identified. Histology and patient data were collected during an average period of more than 5 years to determine tumor stage and type, resection status, complications, tumor recurrence, and distant metastasis. RESULTS: Fifty-one patients who underwent additional surgery were eligible for analysis. Overall, regional LNM was detected in 5 patients (9.8%) and presence of lymphovascular infiltration was a significant risk factor. Surgery-related complications occurred in 3 patients (5.9%). During a median follow-up period of 59 months, no metastasis or local recurrence was observed. Three patients died of other diseases and no CRC-related deaths took place. CONCLUSIONS: Additional surgery after non-curative ESD for ECRC is effective and safe and should be encouraged to foster curative treatment and better long-term outcomes. BioMed Central 2017-11-28 /pmc/articles/PMC5704364/ /pubmed/29183272 http://dx.doi.org/10.1186/s12876-017-0701-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chen, Tao
Zhang, Yi-Qun
Chen, Wei-Feng
Hou, Ying-Yong
Yao, Li-Qing
Zhong, Yun-Shi
Xu, Mei-Dong
Zhou, Ping-Hong
Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
title Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
title_full Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
title_fullStr Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
title_full_unstemmed Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
title_short Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
title_sort efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704364/
https://www.ncbi.nlm.nih.gov/pubmed/29183272
http://dx.doi.org/10.1186/s12876-017-0701-y
work_keys_str_mv AT chentao efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT zhangyiqun efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT chenweifeng efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT houyingyong efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT yaoliqing efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT zhongyunshi efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT xumeidong efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer
AT zhoupinghong efficacyandsafetyofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectionforearlycolorectalcancer